References
- 1. Badgujar B, Mundada A. The technologies used for developing orally disintegrating tablets: A review. Acta Pharm. 2011, 61:117-13910.2478/v10007-011-0020-8
- 2. Bandari S, Mittapalli R, Gannu R, Rao Y. Orodispersible tablets: An overview. Asian Journal of Pharmaceutics. 2008, 2(1):2-11.10.4103/0973-8398.41557
- 3. Battu SK, Repka MA, Majumdar S, Rao Y M. Formulation and Evaluation of Rapidly Disintegrating Fenoverine Tablets: Effect of Superdisintegrants. Drug Development and Industrial Pharmacy. 2007; 33(11):1225-32.10.1080/03639040701377888
- 4. Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, et al. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. The World Journal of Biological Psychiatry. 2010, 11(7):894-903.10.3109/15622975.2010.505663
- 5. Dey P, Maiti S. Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med. 2010, 1(1):2-5.10.4103/0976-9668.71663
- 6. Navarro V. Improving medication compliance in patients with depression: Use of orodispersible tablets. Advances in Therapy. 2010, 27(11):785-95.10.1007/s12325-010-0073-y
- 7. Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011;2(4):223-35.10.4103/2231-4040.90877
- 8. Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical Science & Technology Today. 2000, 3(2):58-63.10.1016/S1461-5347(99)00237-0
- 9. Mohanachandran P, Sindhumol P, Kiran T. Superdisintegrants: an overview. Int J Pharm Sci Rev Res. 2011, 6(1):105-9.
- 10. Shihora H, Panda S. Superdisintegrants, utility in dosage forms: a quick review. J Pharm Sci Biosci Res. 2011, 1(3):148-53.
- 11. Zhao N, Augsburger LL. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS PharmSciTech. 2005, 6(4):E634-E40.10.1208/pt060479275061216408865
- 12. Vijayanand P, Patil JS, Reddy MV. Formulation and comparative pharmacokinetic evaluation of orodispersible tablets and films of nebivolol hydrochloride. J Pharm Investig. 2015, 45(2):237-47.10.1007/s40005-014-0169-5
- 13. Sravani M. Formulation and Evaluation of Mouth Dissolving Tablets of Nebivolol HCl for Treatment of Hypertension. Int. j. pharma chem. res. 2017, 3(4):756-74.
- 14. ****European Pharmacopeeia 10th Edition. 2019:432-567.